SCHEMBL7856205

SCHEMBL7856205

CC(C)C[C@@H](C(=O)NN1C(=O)NC2(CCN(S(=O)(=O)c3ccccc3)CC2)C1=O)[C@H](CCCc1ccccc1)C(=O)NOC1CCCCO1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
MMP1 P03956 2/20 0.38
MMP9 P14780 1/20 0.38
FKBP1A P62942 4/20 0.35
APP P05067 1/20 0.34
KMT2A Q03164 4/20 0.34
GAA P10253 3/20 0.33
MEN1 O00255 3/20 0.33
MAPT P10636 2/20 0.33
MMP13 P45452 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7837542 0.91 MMP1 (0.36) ALDH1A1MMP1FKBP1AAPPKMT2A
SCHEMBL7848793 0.89 MMP1 (0.35) MMP1MMP9FKBP1AAPPMMP13
SCHEMBL7955660 0.88 XIAP (0.35) ALDH1A1MMP1MMP13LMNA
SCHEMBL7946535 0.86 MMP1 (0.37) MMP1MMP9APPKMT2AMMP13
SCHEMBL7946538 0.84 MMP1 (0.41) ALDH1A1MMP1MMP9APPKMT2A
SCHEMBL7946539 0.84 MMP1 (0.41) ALDH1A1MMP1MMP9APPKMT2A
SCHEMBL7955756 0.82 ALDH1A1 (0.36) ALDH1A1MMP1MMP9FKBP1AKMT2A
SCHEMBL7955753 0.82 ALDH1A1 (0.36) ALDH1A1MMP1MMP9FKBP1AKMT2A
SCHEMBL6221034 0.81 MMP1 (0.38) MMP1MMP9FKBP1AAPPMMP13
SCHEMBL7960600 0.80 MMP1 (0.37) MMP1MMP9APPMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1137640-A1 CYCLIC HYDRAZINE DERIVATIVES AS TNF-ALPHA INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2001-10-04 EP disclosed
US-6281363-B1 ANTIINFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS; AUTOIMMUNE DISORDERS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed
WO-2000035885-A1 CYCLIC HYDRAZINE DERIVATIVES AS TNF-ALPHA INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed